Genmab A (GMAB) Revenue (2023 - 2026)
Genmab A (GMAB) reported Revenue of $1.16 billion for the quarter ended Jun 30, 2026, up 28.9% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Revenue (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Genmab A's Revenue came in at $6.35 billion; for the year ended Dec 31, 2025, it came in at $3.72 billion, up 19.2% from the prior year.
- Revenue has increased for five consecutive years, with a five-year compound annual growth rate of 42.5% (years ended Dec 2020 to Dec 2025).
- By year, Revenue came in at $3.12 billion in the year ended Dec 31, 2024 (+30.6%), $2.39 billion in the year ended Dec 31, 2023 (+17.7%), $2.03 billion in the year ended Dec 31, 2022 (+111.9%) and $958.42 million in the year ended Dec 31, 2021 (+51.4%).
- Five-year quarterly Revenue spans a low of $222.83 million in the quarter ended Dec 31, 2021 and a high of $2.66 billion in the quarter ended Sep 30, 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Genmab A | 2.55 Bn | -2.82 Bn | 1.07 Bn | 1.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 896.00 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 925.00 Mn |
| Mar 31, 2025 | 715.00 Mn |
| Sep 30, 2024 | 816.00 Mn |
| Jun 30, 2024 | 779.00 Mn |
| Mar 31, 2024 | 603.00 Mn |
| Dec 31, 2023 | -9.33 Bn |
| Sep 30, 2023 | 4.71 Bn |
API Access
Genmab A Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();